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ABSTRACT
Objective: The Genomic Medicine Working Group of the National Advisory Council for Human Genome Research virtually hosted its 13th genomic medicine meeting titled “Developing a Clinical Genomic Informatics
Research Agenda”. The meeting’s goal was to articulate a research strategy to develop Genomics-based Clinical Informatics Tools and Resources (GCIT) to improve the detection, treatment, and reporting of genetic disorders in clinical settings.
Materials and Methods: Experts from government agencies, the private sector, and academia in genomic medicine and clinical informatics were invited to address the meeting’s goals. Invitees were also asked to complete a
survey to assess important considerations needed to develop a genomic-based clinical informatics research
strategy.
Results: Outcomes from the meeting included identifying short-term research needs, such as designing and
implementing standards-based interfaces between laboratory information systems and electronic health
records, as well as long-term projects, such as identifying and addressing barriers related to the establishment
and implementation of genomic data exchange systems that, in turn, the research community could help address.
Discussion: Discussions centered on identifying gaps and barriers that impede the use of GCIT in genomic medicine. Emergent themes from the meeting included developing an implementation science framework, defining
a value proposition for all stakeholders, fostering engagement with patients and partners to develop applications under patient control, promoting the use of relevant clinical workflows in research, and lowering related
barriers to regulatory processes. Another key theme was recognizing pervasive biases in data and information
systems, algorithms, access, value, and knowledge repositories and identifying ways to resolve them.
Key words: genomics, clinical informatics, clinical decision support systems

INTRODUCTION
The use of genomics in clinical care has advanced our understanding
of the etiology of disease and is leading to improvements in diagnostic screening, disease prevention, and treatment. However, after
years of exciting genomic discoveries relevant to clinical care, there
remain barriers that healthcare providers face when trying to integrate genomics-based data into both the electronic health record
(EHR) and clinical decision support systems (CDSS). Optimal characteristics of genomic information were initially described in the
Technical Desiderata for integrating genomic data into EHRs and
CDSS.1,2 The National Human Genome Research Institute
(NHGRI) has aimed to identify and prioritize these barriers and
stimulate research efforts to resolve them through a series of workshops and related activities. For example, NHGRI’s recently published 2020 strategic vision for the future of genomics includes key
elements for sustaining and improving a robust foundation for genomics.3 These key elements were generated from input from over 50
meetings and events. One key element described in this 2020 strategic vision is the need to invest in research that focuses on improving
the accessibility and usability of genomic information for clinicians
through CDSS and other tools.
Recognizing the importance of integrating genomic information
into EHRs as a significant issue predates the 2020 NHGRI strategic
vision. The Genomic Medicine Working Group (GMWG), a working group of the National Advisory Council for Human Genome Research, focused its 2014 genomic medicine meeting on “Genomic
Clinical Decision Support—Developing Solutions for Clinical and
Research Implementation” (GMVII).4 This meeting involved key
thought leaders in genomic medicine implementation and genomic
clinical decision support (CDS) to define gaps and develop strategies
to resolve them. The GMVII meeting also focused on identifying
and engaging health information technology initiatives to support
recommended strategies and define and prioritize a genomic CDS

implementation research agenda. Informed by the GMVII meeting
and the 2020 NHGRI strategic vision, the GMWG organized its
13th genomic medicine meeting (GMXIII) titled “Genomic Medicine XIII: Developing a Clinical Genomic Informatics Research
Agenda”. The goal of GMXIII was to develop a research strategy to
reduce barriers for the genomics community in developing and using
Genomics-based Clinical Informatics Tools and Resources (GCIT)
to improve the detection, treatment, and reporting of genetic disorders in clinical settings.
The specific objectives of the meeting included:
•
•

•

Define the status of GCIT and related knowledge gaps,
Determine facilitators and barriers that affect the development
and deployment of GCIT research needed to support the former
while also resolving the latter, and
Identify research needed to improve how GCIT affect the
patients and clinician decision-making processes.

This article describes progress in the field from 2014 to 2021,
highlights available GCIT for improving preventive and therapeutic
care, discusses the key themes from the meeting emphasizing progress while identifying new and remaining challenges, and describes
how NHGRI and the scientific community can promote research in
GCIT.

METHODS
The speakers and moderators were invited by a GMXIII planning
committee and the GMWG based on their content expertise. The
participants included experts in genomic medicine, clinical informatics, clinical medicine, research, and health policy as well as representatives from the National Institutes of Health. Each session also
included a moderated discussion component to allow attendees to
share their experiences and to identify and prioritize barriers that
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NHGRI should consider in their plans to stimulate research in
GCIT. The meeting was recorded (https://youtu.be/DUp7JLeL8iM)
and dedicated note-takers summarized the sessions. After the meeting, presentations and associated discussions were reviewed by the
planning committee, the GMWG, and NHGRI staff to identify key
themes and create a meeting summary (https://www.genome.gov/
event-calendar/genomic-medicine-xiii-developing-a-clinical-genomic-informatics-research-agenda). The summary was reviewed,
edited, and approved by all speakers, moderators, and the GMWG
and NHGRI staff.5
In advance of the meeting, a survey was circulated to invitees to
gather feedback on progress made in addressing the elements that
are described in the “Technical Desiderata for the Integration of Genomic Data into Electronic Health Records”2 and the “Technical
Desiderata for the Integration of Genomic Data with Clinical Decision Support”1 (Supplemental Table S1a). To reflect the changes in
the genomics and informatics landscapes since these publications
and to support the collection of information relevant to the objectives of the meeting, the planning committee considered developing
additional questions. Eight additional questions were included in the
survey and were vetted by the GMWG and NHGRI staff (Supplemental Table S1b). Respondents were asked to rate the importance
of the elements of the Technical Desiderata using a 5-point Likert
scale (1—strongly agree to 5—strongly disagree). A “don’t know”
response option was also provided. The survey responses were collected using QualtricsV. The mean and standard deviation of the
responses were obtained. Respondents also had the opportunity to
rank the importance of the 14 desiderata elements and provide freetext responses on barriers and gaps involving the development and
implementation of GCIT. The planning committee reviewed these
surveys to identify points to guide discussion for the GMXIII workshop. Before the meeting, narrative comments relevant to specific
content areas were provided to speakers for incorporation into their
presentations. Finally, the GMXIII meeting was divided into 6 sessions, and the review group identified priority themes from each session (Table 1).
R

•

The genomic medicine community has not adequately addressed
efforts to modify clinical workflows to reduce instances of “alert
fatigue”.

Results from the survey and a copy of the survey questions can
be found in the Supplemental Materials. Prioritization of the desiderata had also been assessed in GMVII, which had 25 out of 35
attendees (83% response rate) complete a similar survey to that used
in GMXIII. The results of the priority ranking from the 2 surveys
conducted 7 years apart are shown in Table 2. Two items were high
priorities at both meetings: “CDS knowledge must have the potential to incorporate multiple genes and clinical information” and
“CDS knowledge must have the capacity to support multiple EHR
platforms with various data representations with minimal modification.” However, several items showed significant changes in priority between the 2 meetings. Three items—“Leverage current and
developing CDS and genomics standards,” “Maintain linkage of
molecular observations to the laboratory methods used to generate
them,” and “Maintain separation of primary molecular observations from the clinical interpretations of those data”—had relatively
low priority in GMVII but had a higher priority in GMXIII. In contrast, “Support a CDS knowledge base deployed at, and developed
by multiple independent organizations” and “Simultaneously support human-viewable formats and machine-readable formats to facilitate implementation of decision support rules” were given a
relatively low priority in GMXIII compared to GMVII. Many
respondents provided free-text responses (Supplemental Materials).
Analysis of the responses identified 4 additional elements not represented in the desiderata:
•
•
•
•

Importance of assessing stakeholder preference and workflow;
Sustainability of resources;
Lack of methods for evaluation of innovation and implementation of GCIT tools; and
Impact of the consent and regulatory framework.

DISCUSSION
RESULTS
One hundred fifty individuals attended the GMXIII meeting, including 2 co-chairs, 16 speakers, and 10 moderators. A full meeting report can be found on the GMXIII meeting site.5 Surveys were sent
to 83 early registrants, all invited speakers, and moderators. Thirtythree participants provided a response (39.8% response rate), and
all who started the survey completed all questions. The key findings
(unprioritized) from the survey include the following:
•
•

•

•

•

The genomic medicine community can benefit from a revised
Technical Desiderata document;
Current methods for storing genomic and genomics-based information are not adequate to allow CDSS to incorporate and support multiple genes and associated clinical information;
Methods related to ontology management and knowledge representation for genomics-based clinical interpretation have not
been adequately addressed by the research community;
Methods for integrating analytical interpretations derived by
computational models of genomic data into clinical settings are
not well established;
Methods for evaluating the clinical utility of GCIT are fluid and
not well defined for the research community to use in their research and development plans; and

The outcomes of GMXIII make a strong case for developing an informatics implementation research agenda to focus on improving
how GCIT impacts patients and the clinical decision-making processes. The ability to compare priorities, barriers, and facilitators
across the 7 years between GMVII and GMXIII was particularly
useful in defining elements of a research agenda, even though the
foci of the 2 meetings were somewhat different. While some progress has been made, many of the barriers identified in the 2014
GMVII meeting are still present in 2021. The top priority issue from
both the surveys is the need to incorporate multiple genes and related clinical information into CDS systems that are integrated into
EHRs. This priority was also reinforced in free-text comments
reflecting the desire by more groups to implement genomic medicine
in the clinic. Elements that maintained the same ranking in both the
GMVII and GMXIII meetings suggest a need for a patient-centered
research agenda to develop innovative platforms for obtaining and
returning genetic tests. Elements that received higher priorities in the
GMXIII survey, compared to GMVII survey, also highlight a need
for researchers to engage across a broader range of organizations to
work collaboratively in addressing these elements. Consistent with
this, the use of existing or developing standards for both genomic
data and CDS moved to a higher priority in the 2021 GMXIII survey compared to the 2014 GMVII survey responses. These results
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Table 1. GMXIII title sessions, objectives, and recommendations
Session title

Making the case for a clinical genomic
informatics research strategy

Objective

Highlight the current state of GCIT efforts in
reducing barriers to implementing and
advancing genomic medicine.

Attendees’ recommendations to address
objectives
•

•

•

•

Need for research in advanced technologies
(AT) to support Genomic Medicine

Researching the stakeholder perspective:
enablers and barriers that affect the integration
of genomics-based clinical informatics
resources in the healthcare system

Identify areas that need support in the
development and implementation of AT to
advance genomic medicine, including
technology for improving genomic medicine
implementation in healthcare delivery both
within and outside of the traditional patient
visit.

•

Describe the necessary partnerships,
collaborations, and processes needed to
generate a sustainable GCIT research
strategy.



•

•





Defining a research agenda that addresses
the process for developing genomics-based
clinical informatics resources

Explore the role health information
technologies play in advancing research in
genomic medicine.

•

•

•

Genomics in a fragmented healthcare
environment

GCIT’s quality improvement strategies,
genomic medicine practice innovations,
outcomes data collection, and analysis.

•

•

•

Identify elements from the survey and the
Technical Desiderata where significant progress has been made and identify those that require additional engagement;
Ensure that the development and implementation of GCIT is done in a manner that
includes equitable representation from diverse
and underserved populations;
Ensure innovative research questions and
methods address inherent biases in a rigorous
and systemic manner;
Report outcomes from GCIT efforts that capture outcome data on both the benefits and
harms of GCIT in their use in CDS to improve
mitigation approaches.
Invest in research that advances a patient-centered approach in the development and implementation of AT;
Ensure that research in AT conducted by the
genomics research community complements
efforts in the private sector;
Support research that generates outcomes that
can be used to inform the business model of
AT in a manner that attracts a broad range of
stakeholders in understanding more about the
incentives to implement these tools and
resources.
Incentivize collaborations in the development,
implementation, and maintenance of a learning healthcare system for genomic medicine;
Incorporate educational and policy research
components that focus on reducing barriers
and improving knowledge for patients and
providers;
Focus on the development, implementation,
and maintenance of genomics-based workflows that:
 Diminish burdens for primary care and
specialty providers;
 Involve the full health care team and engage patients;
 Go beyond alerts and reminders to disseminate meaningful information for
CDS.
Focus on the interface of human cognition
and artificial intelligence to leverage the best
of both approaches to improve patient care;
Lower the regulatory barriers for the development and implementation of GCIT without
compromising patient safety;
Develop and implement a common semantic
framework that enables interoperability and
reduces reliance on manual curation.
Invest in the development of specific use cases
that support genomic medicine implementation through informatics;
Invest in research that focuses on establishing
a genomics-based health information exchange system in a manner that synergizes
with the broader health information technology community’s efforts in this space;
Support efforts that facilitate not only the development of GCIT but also the “last mile” of clinical implementation into healthcare systems.
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Table 2. GMVII and GMXIII Technical Desiderata elements ranking for the integration of genomic data into electronic health records and
clinical decision support
Technical Desiderata elements

Maintain separation of primary molecular observations from the
clinical interpretations of those data
Maintain linkage of molecular observations to the laboratory
methods used to generate them
Support lossless data compression from primary molecular
observations to clinically manageable subsets
Leverage current and developing CDS and genomics standards
Keep CDS knowledge separate from variant classification
Support a large number of gene variants while simplifying the
CDS knowledge to the extent possible
CDS knowledge must have the potential to incorporate multiple
genes and clinical information
CDS knowledge must have the capacity to support multiple EHR
platforms with various data representations with minimal modification
Access and transmit only the genomics information necessary for CDS
Support a CDS knowledge base deployed at and developed by
multiple independent organizations
Simultaneously support human-viewable formats and machine-readable
formats in order to facilitate implementation of decision support rules
Support both individual clinical care and discovery science
Support compact representation of clinically actionable subsets for
optimal performance
Anticipate fundamental changes in the understanding of human
molecular variation

GMVII
Ranking, 2014

GMXIII
Ranking, 2021

Ranking changes
over 7 years

11

3

þ8

7

2

þ5

12

6

þ6

8
13
9

4
11
7

þ4
þ2
þ2

1

1

¼

5

5

¼

14
4

14
12

¼
8

3

10

7

2
6

8
9

6
3

10

13

3

Note:
¼ element received a higher ranking in the GMXIII survey than the GMVII survey.
survey than the GMVII survey.

could be indicative of survey respondents’ biases. However, the
results could also be attributed to the recent emergence of genomic
data standards, such as those developed by the Global Alliance for
Genomics & Health (GA4GH), the genomic standards consortium,
and the Health Level Seven’s Fast Healthcare Interoperability
ResourcesV (FHIRV). Two items—CDS knowledge base and support
for human and machine-readable CDS—had much lower priority
based on the 2021 GMXIII survey response than the 2014 GMVII
survey response, possibly because progress has been made.6,7 However, research opportunities in these areas are still present.
Several new priorities were identified from the meetings that were
not described in the 2 surveys. Prioritization of issues such as stakeholder engagement, workflow assessment, measurement of effectiveness and outcomes of implemented systems, development of
educational and support materials, regulatory and policy analysis, and
assessment of equity for diverse and underrepresented communities indicate that more attention is being directed towards issues critical to
the implementation of genomic medicine. These priorities have significant implications for any research agenda. Specifically, the incorporation of expanded research methods emerged as an important
overarching theme. Examples include using methods and models from
various disciplines, including implementation science, user-centered
engagement and design, business case analysis, and workflow analysis.
Equity and inclusion were recurring themes that arose in many of
the sessions. Clinical genomics research, including related informatics
tools and resources, must acknowledge how race, ethnicity, ancestry,
gender, and other social determinants of health impact genomic medicine and clinical implementation of genomic information. For example,
Black and Hispanic patients are less likely than White patients to be referred to or included by default into screening programs based on obR

R

¼ element received a lower ranking in the GMXIII

served genetic risk, even after adjusting for disease-specific population
allele frequencies.8,9 Total medical expenditures per capita are roughly
similar between Black and White populations even though Black populations are sicker.10,11 GCIT research methods must include ways to
identify and mitigate inherent and pervasive biases impacting data,
knowledge, infrastructure support in EHR systems, access, and value
definitions that interfere with the meaningful and beneficial use of genomics in clinical care. Genomic medicine specialists must be antiracist
and proactively seek to identify and remove harmful biases that affect
data and systems used for research and clinical care. GCIT need to include education, training, and policy components that reduce barriers
and improve knowledge for patients and providers. The goal of clinical
informatics and EHR integration of genomics and related information
should be to support research that proactively and explicitly improves
outcomes, avoids increasing clinicians’ workloads, and addresses systemic biases in data, information systems, and clinical care delivery.
Attendees strongly supported substantive stakeholder engagement at
all points of GCIT in languages that users can understand and employ to
reduce barriers in improving knowledge for patients and providers.
Efforts to develop GCIT must include individuals from diverse backgrounds and experiences, monitoring for bias and discrimination at different stages of development and implementation, establishing robust equity
policies, and having developers work with patient engagement groups before, during, and after any GCIT initiative. Research based on clinically
meaningful use cases as defined by patients, clinicians, and other stakeholders is essential to attain these research objectives. GCIT research
needs to note the importance of engaging with diverse institutions with
intentional outreach to institutions and delivery systems not typically represented in informatics and genomics research to address the lack of diversity at the institutional level and improve the generalizability of results.
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Table 3. Short-term projects (1–3 year timeline)
Developing new and modifying existing tools and workflows to address systemic bias in genomics-based data and information systems used in health
IT
Revising the Technical Desiderata
Developing user-friendly clinician- and patient-centered genomics-based tools and workflows
Identifying and addressing semantic and syntactic gaps related to the representation of genomic information in existing clinical data standards and
models
Developing and implementing genomics-based computational tools that automatically extract clinical genomic evidence from variant interpretation to
reduce manual curation
Generating evidence from research focused on end-user prioritized use cases to standardize both dynamic genome annotation and its interpretation for
clinical care

Table 4. Long-term projects (4–5 year timeline)
Developing efficient, portable, and user-friendly storage of genomic and genomics-based information for clinical use
Studying genomics-based CDS tools and resources that ensure equitable implementation so resource-limited communities are not left behind
Developing and assessing the value proposition for genomics-based clinical informatics systems
Developing and implementing genomics-based interfaces between laboratory information systems and the electronic health record
Identifying and addressing barriers related to the establishment and implementation of genomic exchange systems

GCIT research requires both scalable and sustainable infrastructures
to foster a robust exchange of genomics-based health information.
However, there currently is not an agreed-upon approach in establishing such infrastructures. There is a need for developing scalable, sharable, and computable genomic knowledgebases that are harmonized
with practice guidelines and clinical workflows. Cloud-based platforms
offer a potential solution to address the scalability needs of the GCIT
community.12–14 For example, The NHGRI Genomic Data Science
Analysis, Visualization, Informatics-Lab space (AnVIL) is a cloud-based
resource developed to analyze, store, and share genomic, as well as associated clinical and molecular data for the basic and clinical genomics research community.15 However, research is needed to understand better
how the clinical community can leverage cloud platforms to address
costs and efficiency while balancing accessibility and security.16
Shareability is essential for the access and representation of data.
Currently, there is no single standard for representing genomicsbased information in a structured format that is commonly integrated into the EHR. Several groups, including the Health Level
Seven InternationalV Clinical Genomics Work Group,17 Sync for
Genes,18 and the GA4GH,19 are working in this area. NHGRI has
also encouraged efforts to develop ways to leverage the HL7 FHIRV
specification to represent genomics-based information,20,21 as well
as efforts to develop and implement technical standards for the interpretation and reporting of genomic variant information for clinical use.22 However, additional research is needed to better
understand the barriers that hinder the development and implementation of genomics-relevant standards into EHR and CDS systems.
Standardized approaches to implementing CDS in the EHR, including valuable tools such as Open Infobutton23 and CDS Hooks,7 are
2 examples developed to address these barriers. The role of Infobuttons has been studied in the context of genomics,23 but implementation in EHR systems remains limited. Research on improving the
processes for integrating and evaluating new genomics-based data
elements for either limited or extensive use in EHR systems has the
potential to be incorporated into the United States Core Data for Interoperability.24 Therefore, the clinical informatics community
should stimulate a multidisciplinary research agenda that creates
sustainable and scalable infrastructures to support genomic data colR

R

lection and its use in a standardized manner. Such an agenda can
also address key issues such as interconnectedness, security, establishing a networked ecosystem, and privacy concerns while promoting research, empowering patients, and promoting diversity.
Development and evaluation of outcomes that are important to
researchers and stakeholders should be included when producing
plans to develop and implement GCIT for the clinical genomics research community. Stimulating research in these areas will assist in
developing and standardizing methods for integrating genomic data
into clinical settings and address barriers associated with the “last
mile” of implementation—actually getting GCIT into clinical use. In
addition, such research coupled with novel approaches, like business
case analysis, will aid in revising the current business models to encourage the development, implementation, and sustainability of
open source genomics-based tools and resources. Healthcare provider decision-makers should also be engaged to determine what evidence is required to increase institutional funding of GCIT. These
efforts will assist in identifying the critical research needed in improving the economics of developing and implementing GCIT.
Based on the presentations and discussions covered during the
GMXIII meeting, several valuable research opportunities were identified. These projects were parsed into those that might be completed in short-term (1–3 years) and long-term (4–5 years) timelines
(see Tables 3 and 4, respectively).
The GMXIII and GMVII meetings provided members from the
informatics community to identify opportunities for improving
GCIT in clinical care. However, both meetings had limitations. For
example, both meetings had an emphasis on engagement in future
research and included attendees who were familiar with the subjects
covered in both workshops. The workshops’ emphasis and invited
attendees introduced a bias since they represented mainly early
adopters and innovators and not the broader informatic community.
Also, both surveys had a good response rate from participants but
there is always the issue of different perspectives in the nonresponders which are not captured. To mitigate this concern, the meetings
were organized to provide extensive time for broader participation
and discussion. This also allowed for participants to identify emergent themes that were not captured in the surveys.
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CONCLUSION
The GMXIII meeting, building on initial ideas arising from GMVII
and incorporating priorities from the 2020 NHGRI strategic vision,
summarized, identified, and prioritized the critical knowledge gaps
in the development, implementation, and evaluation of GCIT.
While many challenges from GMVII persist, new priorities were
identified in the areas of equity and inherent bias, end-user engagement in the context of real-world clinical use cases to develop solutions that are more likely to be implemented, and sustainability of
open-source solutions. Incorporating a broader range of methods
that draw from disciplines such as implementation science, outcomes research, business case analyses, and other disciplines is
needed to emphasize pragmatic approaches to research questions.
These are all aligned with the 2020 NHGRI strategic vision and
will be important in guiding future research.
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